Harnessing the platelet signaling network to produce an optimal hemostatic response

Hematology/Oncology Clinics of North America

Volumn 27, Issue 3, 2013, Pages 381-409

  Brass, Lawrence F ^a   Tomaiuolo, Maurizio ^a   Stalker, Timothy J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

G protein coupled receptors; G proteins; Hemostasis; Integrins; Networks; Platelets; Signal transduction; Vascular injury

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; CALCIUM ION; COLLAGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; SEMAPHORIN; THROMBIN; THROMBOXANE A2;

ACTIN FILAMENT; BLOOD VESSEL INJURY; CYTOSOL; ENZYME ACTIVATION; HEMOSTASIS; HUMAN; HYDROLYSIS; LIGAND BINDING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBUS;

ANIMALS; BLOOD PLATELETS; HEMOSTASIS; HUMANS; PLATELET ACTIVATION; SIGNAL TRANSDUCTION;

EID: 84878263829     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2013.02.002     Document Type: Review

References (184)

1. Kanaji S., Fahs S.A., Shi Q., et al. Contribution of platelet versus endothelial VWF to platelet adhesion and hemostasis. J Thromb Haemost 2012, 10(8):1646-1652.
2. Reininger A.J., Heijnen H.F., Schumann H., et al. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 2006, 107:3537-3545.
3. Ruggeri Z.M., Orje J.N., Habermann R., et al. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006, 108:1903-1910.
4. Munnix I.C., Cosemans J.M., Auger J.M., et al. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009, 102:1149-1156.
5. Nesbitt W.S., Westein E., Tovar-Lopez F.J., et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009, 15:665-673.
6. Bellido-Martin L., Chen V., Jasuja R., et al. Imaging fibrin formation and platelet and endothelial cell activation in vivo. Thromb Haemost 2011, 105:776-782.
7. Nishimura S., Manabe I., Nagasaki M., et al. In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling. Blood 2012, 119:e45-e56.
8. Brass L.F., Wannemacher K.M., Ma P., et al. Regulating thrombus growth and stability to achieve an optimal response to injury. J Thromb Haemost 2011, 9(Suppl 1):66-75.
9. Italiano J.E., Richardson J.L., Patel-Hett S., et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008, 111:1227-1233.
10. Peters C.G., Michelson A.D., Flaumenhaft R. Granule exocytosis is required for platelet spreading: differential sorting of alpha-granules expressing VAMP-7. Blood 2012, 120:199-206.
11. Battinelli E.M., Markens B.A., Italiano J.E. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 2011, 118:1359-1369.
12. Kamykowski J., Carlton P., Sehgal S., et al. Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet alpha-granules. Blood 2011, 118:1370-1373.
13. Kato K., Martinez C., Russell S., et al. Genetic deletion of mouse platelet glycoprotein Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size. Blood 2004, 104:2339-2344.
14. Brass L.F., Vassallo R.R., Belmonte E., et al. Structure and function of the human platelet thrombin receptor: studies using monoclonal antibodies against a defined epitope within the receptor N-terminus. J Biol Chem 1992, 267:13795-13798.
15. Mills D.C. ADP receptors on platelets. Thromb Haemost 1996, 76:835-856.
16. Gachet C., Hechler B., Léon C., et al. Activation of ADP receptors and platelet function. Thromb Haemost 1997, 78:271-275.
17. Daniel J.L., Dangelmaier C., Jin J.G., et al. Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998, 273:2024-2029.
18. Jin J.G., Daniel J.L., Kunapuli S.P. Molecular basis for ADP-induced platelet activation II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998, 273:2030-2034.
19. Hollopeter G., Jantzen H.M., Vincent D., et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001, 409:202-207.
20. Motulsky H.J., Insel P.A. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine. Biochem Pharmacol 1982, 31:2591-2597.
21. Offermanns S. In vivo functions of heterotrimeric G-proteins: studies in Galpha-deficient mice. Oncogene 2001, 20:1635-1642.
22. Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010, 11:288-300.
23. Brass L.F., Bensusan H.B. The role of collagen quaternary structure in the platelet: collagen interaction. J Clin Invest 1974, 54:1480-1487.
24. Santoro S.A. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986, 46:913-920.
25. Brass L.F., Faile D., Bensusan H.B. Direct measurement of the platelet: collagen interaction by affinity chromatography on collagen/Sepharose. J Lab Clin Med 1976, 87:525-534.
26. Clemetson J.M., Polgar J., Magnenat E., et al. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999, 274:29019-29024.
27. Massberg S., Gawaz M., Gruner S., et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003, 197:41-49.
28. Kato K., Kanaji T., Russell S., et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003, 102:1701-1707.
29. Poole A., Gibbins J.M., Turner M., et al. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 1997, 16:2333-2341.
30. Nieswandt B., Brakebusch C., Bergmeier W., et al. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J 2001, 20:2120-2130.
31. Keely P.J., Parise L.V. The alpha2beta1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cgamma2 in platelets. J Biol Chem 1996, 271:26668-26676.
32. Consonni A., Cipolla L., Guidetti G., et al. Role and regulation of phosphatidylinositol 3-kinase beta in platelet integrin alpha2beta1 signaling. Blood 2012, 119:847-856.
33. Nieuwenhuis H.K., Akkerman J.W., Houdijk W.P., et al. Human blood platelets showing no response to collagen fail to express glycoprotein Ia. Nature 1985, 318:470-472.
34. Sixma J.J., Van Zanten G.H., Huizinga E.G., et al. Platelet adhesion to collagen: an update. Thromb Haemost 1997, 78:434-438.
35. Kuijpers M.J., Schulte V., Bergmeier W., et al. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. FASEB J 2003, 17:685-687.
36. Schmaier A.A., Zou Z., Kazlauskas A., et al. Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role. Proc Natl Acad Sci U S A 2009, 106:21167-21172.
37. Nesbitt W.S., Giuliano S., Kulkarni S., et al. Intercellular calcium communication regulates platelet aggregation and thrombus growth. J Cell Biol 2003, 160:1151-1161.
38. Kulkarni S., Nesbitt W.S., Dopheide S.M., et al. Techniques to examine platelet adhesive interactions under flow. Methods Mol Biol 2004, 272:165-186.
39. Offermanns S., Toombs C.F., Hu Y.H., et al. Defective platelet activation in Galphaq-deficient mice. Nature 1997, 389:183-186.
40. Moers A., Nieswandt B., Massberg S., et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 2003, 9:1418-1422.
41. Barr A.J., Brass L.F., Manning D.R. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells: a direct evaluation of selectivity in receptor-G protein coupling. J Biol Chem 1997, 272:2223-2229.
42. Kim S., Foster C., Lecchi A., et al. Protease-activated receptor 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood 2002, 99:3629.
43. Vu T.K., Hung D.T., Wheaton V.I., et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991, 64:1057-1068.
44. Connolly A.J., Ishihara H., Kahn M.L., et al. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996, 381:516-519.
45. Griffin C.T., Srinivasan Y., Zheng Y.W., et al. A role of thrombin receptor signaling in endothelial cells during embryonic development. Science 2001, 293:1666-1670.
46. Nakanishi-Matsui M., Zheng Y.W., Sulciner D.J., et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000, 404:609-610.
47. Xu W.F., Andersen H., Whitmore T.E., et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A 1998, 95:6642-6646.
48. Kahn M.L., Zheng Y.W., Huang W., et al. A dual thrombin receptor system for platelet activation. Nature 1998, 394:690-694.
49. Ishii K., Gerszten R., Zheng Y.W., et al. Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate. J Biol Chem 1995, 270:16435-16440.
50. Covic L., Gresser A.L., Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 2000, 39:5458-5467.
51. Shapiro M.J., Weiss E.J., Faruqi T.R., et al. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 2000, 275:25216-25221.
52. Kahn M.L., Nakanishi-Matsui M., Shapiro M.J., et al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999, 103:879-887.
53. Sambrano G.R., Weiss E.J., Zheng Y.-W., et al. Role of thrombin signaling in platelets in hemostasis and thrombosis. Nature 2001, 413:74-78.
54. Jin J.G., Kunapuli S.P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A 1998, 95:8070-8074.
55. Brass L.F., Woolkalis M.J. Dual regulation of cAMP formation by thrombin in HEL cell, a leukemic cell line with megakaryocytic properties. Biochem J 1992, 281:73-80.
56. Brass L.F., Woolkalis M.J., Manning D.R. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. J Biol Chem 1988, 263:5348-5355.
57. Signarvic R.S., Cierniewska A., Stalker T.J., et al. RGS/Gi2alpha interactions modulate platelet accumulation and thrombus formation at sites of vascular injury. Blood 2010, 116:6092-6100.
58. De Cristofaro R., De Candia E., Rutella S., et al. The Asp272-Glu282 region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III. J Biol Chem 2000, 275:3887-3895.
59. Celikel R., McClintock R.A., Roberts J.R., et al. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science 2003, 301:218-221.
60. De Marco L., Mazzucato M., Masotti A., et al. Function of glycoprotein Ibalpha in platelet activation induced by alpha-thrombin. J Biol Chem 1991, 266:23776-23783.
61. Harmon J.T., Jamieson G.A. Platelet activation by thrombin in the absence of the high affinity thrombin receptor. Biochemistry 1988, 27:2151-2157.
62. Mazzucato M., De Marco L., Masotti A., et al. Characterization of the initial alpha-thrombin interaction with glycoprotein Ibalpha in relation to platelet activation. J Biol Chem 1998, 273:1880-1887.
63. De Candia E., Hall S.W., Rutella S., et al. Binding of thrombin to glycoprotein Ib accelerates hydrolysis of PAR1 on intact platelets. J Biol Chem 2001, 276:4692-4698.
64. Dörmann D., Clemetson K.J., Kehrel B.E. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000, 96:2469-2478.
65. Tello-Montoliu A., Tomasello S.D., Ueno M., et al. Antiplatelet therapy: thrombin receptor antagonists. Br J Clin Pharmacol 2011, 72:658-671.
66. Morrow D.A., Braunwald E., Bonaca M.P., et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med 2012, 366:1404-1413.
67. Tricoci P., Huang Z., Held C., et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med 2012, 366:20-33.
68. Scirica B.M., Bonaca M.P., Braunwald E., et al. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2 degrees P-TIMI 50 trial. Lancet 2012, 380(9850):1317-1324.
69. Fisher G.J., Bakshian S., Baldassare J.J. Activation of human platelets by ADP causes a rapid rise in cytosolic free calcium without hydrolysis of phosphatidylinositol-4,5-bisphosphate. Biochem Biophys Res Commun 1985, 129:958-964.
70. Daniel J.L., Dangelmaier C.A., Selak M., et al. ADP stimulates IP3 formation in human platelets. FEBS Lett 1986, 206:299-303.
71. Léon C., Hechler B., Vial C., et al. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 1997, 403:26-30.
72. Zhang F.L., Luo L., Gustafson E., et al. ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 2001, 276:8608-8615.
73. McKenzie A.B., Mahout-Smith M.P., Sage S.O. Activation of receptor-operated channels via P2X1 not P2T purinoreceptors in human platelets. J Biol Chem 1996, 271:2879-2881.
74. Vial C., Hechler B., Léon C., et al. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost 1997, 78:1500-1504.
75. Sun B., Li J., Okahara K., et al. P2X1 purinoceptor in human platelets-molecular cloning and functional characterization after heterologous expression. J Biol Chem 1998, 273:11544-11547.
76. Mahaut-Smith M.P., Ennion S.J., Rolf M.G., et al. ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Psychol 2000, 131:108-114.
77. Fung C.Y., Brearley C.A., Farndale R.W., et al. A major role for P2X1 receptors in the early collagen-evoked intracellular Ca2+ responses of human platelets. Thromb Haemost 2005, 94:37-40.
78. Mahaut-Smith M.P., Tolhurst G., Evans R.J. Emerging roles for P2X1 receptors in platelet activation. Platelets 2004, 15:131-144.
79. Hechler B., Lenain N., Marchese P., et al. A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med 2003, 198:661-667.
80. Tolhurst G., Vial C., Leon C., et al. Interplay between P2Y(1), P2Y(12), and P2X(1) receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling. Blood 2005, 106:1644-1651.
81. Soulet C., Hechler B., Gratacap M.P., et al. A differential role of the platelet ADP receptors P2Y and P2Y in Rac activation. J Thromb Haemost 2005, 3:2296-2306.
82. Nurden P., Savi P., Heilmann E., et al. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest 1995, 95:1612-1622.
83. Foster C.J. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine drugs using P2Yac-null mice. J Clin Invest 2001, 107:1591-1598.
84. Jantzen H.M., Milstone D.S., Gousset L., et al. Impaired activation of murine platelets lacking Galphai2. J Clin Invest 2001, 108:477-483.
85. Yang J., Wu J., Jiang H., et al. Signaling through Gi family members in platelets-redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J Biol Chem 2002, 277:46035-46042.
86. Yang J., Wu J., Kowalska M.A., et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci U S A 2000, 97:9984-9989.
87. Cattaneo M., Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999, 19:2281-2285.
88. Fabre J.E., Nguyen M.T., Latour A., et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999, 5:1199-1202.
89. Léon C., Hechler B., Freund M., et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. J Clin Invest 1999, 104:1731-1737.
90. Paul B.Z., Jin J.G., Kunapuli S.P. Molecular mechanism of thromboxane A2-induced platelet aggregation-essential role for P2TAC and alpha2A receptors. J Biol Chem 1999, 274:29108-29114.
91. Nash C.A., Severin S., Dawood B.B., et al. Src family kinases are essential for primary aggregation by G(i)-coupled receptors. J Thromb Haemost 2010, 8:2273-2282.
92. Gerrard J.M., Carroll R.C. Stimulation of protein phosphorylation by arachidonic acid and endoperoxide analog. Prostaglandins 1981, 22:81-94.
93. FitzGerald G.A. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am J Correct 1991, 68:11B-15B.
94. Brass L.F., Shaller C.C., Belmonte E.J. Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin. J Clin Invest 1987, 79:1269-1275.
95. Hirata T., Ushikubi F., Kakizuka A., et al. Two thromboxane A2 receptor isoforms in human platelets-opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 1996, 97:949-956.
96. Gao Y., Tang S., Zhou S., et al. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 2001, 296:426-433.
97. Thomas D.W., Mannon R.B., Mannon P.J., et al. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 1998, 102:1994-2001.
98. Higuchi W., Fuse I., Hattori A., et al. Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity. Thromb Haemost 1999, 82:1528-1531.
99. Rao A.K., Willis J., Kowalska M.A., et al. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelpha2-adrenergic receptor defect. Blood 1988, 71:494-501.
100. Tamponi G., Pannocchia A., Arduino C., et al. Congenital deficiency of alpha2-adrenoreceptors on human platelets: description of two cases. Thromb Haemost 1987, 58:1012-1016.
101. Newman K.D., Williams L.T., Bishopric N.H., et al. Identification of alpha-adrenergic receptors in human platelets by 3H-dihydroergocryptine binding. J Clin Invest 1978, 61:395-402.
102. Kaywin P., McDonough M., Insel P.A., et al. Platelet function in essential thrombocythemia: decreased epinephrine responsivenesss associated with a deficiency of platelet alpha-adrenergic receptors. N Engl J Med 1978, 299:505-509.
103. Siess W., Weber P.C., Lapetina E.G. Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. J Biol Chem 1984, 259:8286-8292.
104. Williams A., Woolkalis M.J., Poncz M., et al. Identification of the pertussis toxin-sensitive G proteins in platelets, megakaryocytes and HEL cells. Blood 1990, 76:721-730.
105. Woulfe D., Jiang H., Mortensen R., et al. Activation of Rap1B by Gi family members in platelets. J Biol Chem 2002, 277:23382-23390.
106. Heemskerk J.W., Willems G.M., Rook M.B., et al. Ragged spiking of free calcium in ADP-stimulated human platelets: regulation of puff-like calcium signals in vitro and ex vivo. J Physiol 2001, 535:625-635.
107. Heemskerk J.W., Hoyland J., Mason W.T., et al. Spiking in cytosolic calcium concentration in single fibrinogen-bound fura-2-loaded human platelets. Biochem J 1992, 283:379-383.
108. Purvis J.E., Chatterjee M.S., Brass L.F., et al. A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation. Blood 2008, 112:4069-4079.
109. Varga-Szabo D., Braun A., Nieswandt B. STIM and Orai in platelet function. Cell Calcium 2011, 50:270-278.
110. Crittenden J.R., Bergmeier W., Zhang Y., et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004, 10:982-986.
111. Rittenhouse-Simmons S., Deykin D. Release and metabolism of arachidonate in human platelets. Platelets in biology and pathology-2 1981, 349-372. Elsevier/North-Holland. J.L. Gordon (Ed.).
112. Rittenhouse-Simmons S., Russell F.A., Deykin D. Mobilization of arachidonic acid in human platelets. Kinetics and Ca2+ dependency. Biochim Biophys Acta 1977, 488:370-380.
113. Börsch-Haubold A.G., Ghomashchi F., Pasquet S., et al. Phosphorylation of cytosolic phospholipase A2 in platelets is mediated by multiple stress-activated protein kinase pathways. Eur J Biochem 1999, 265:195-203.
114. Börsch-Haubold A.G., Kramer R.M., Watson S.P. Cytosolic phospholipase A2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J Biol Chem 1995, 270:25885-25892.
115. Jin J.G., Quinton T.M., Zhang J., et al. Adenosine diphosphate (ADP)-induced thromboxane A2 generation in human platelets requires coordinated signaling through integrin alphaIIBbeta3 and ADP receptors. Blood 2002, 99:193-198.
116. Klages B., Brandt U., Simon M.I., et al. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 1999, 144:745-754.
117. Fukuhara S., Chikumi H., Gutkind J.S. RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho?. Oncogene 2001, 20:1661-1668.
118. Wilde J.I., Retzer M., Siess W., et al. ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation. Platelets 2000, 11:286-295.
119. Pandey D., Goyal P., Bamburg J.R., et al. Regulation of LIM-kinase 1 and cofilin in thrombin-stimulated platelets. Blood 2005, 107:575-583.
120. Woulfe D., Jiang H., Morgans A., et al. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 2004, 113:441-450.
121. Chen J., De S., Damron D.S., et al. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004, 104:1703-1710.
122. O'Brien K.A., Stojanovic-Terpo A., Hay N., et al. An important role for Akt3 in platelet activation and thrombosis. Blood 2011, 118:4215-4223.
123. Jackson S.P., Schoenwaelder S.M., Goncalves I., et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005, 11:507-514.
124. Brass L.F., Zhu L., Stalker T.J. Minding the gaps to promote thrombus growth and stability. J Clin Invest 2005, 115:3385-3392.
125. Shattil S.J. The beta3 integrin cytoplasmic tail: protein scaffold and control freak. J Thromb Haemost 2009, 7(Suppl 1):210-213.
126. Prevost N., Kato H., Bodin L., et al. Platelet integrin adhesive functions and signaling. Meth Enzymol 2007, 426:103-115.
127. Stegner D., Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med 2011, 89:109-121.
128. Shattil S.J., Newman P.J. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004, 104:1606-1615.
129. Calderwood D.A., Ginsberg M.H. Talin forges the links between integrins and actin. Nat Cell Biol 2003, 5:694-697.
130. Calderwood D.A., Zent R., Grant R., et al. The talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 1999, 274:28071-28074.
131. Tadokoro S., Shattil S.J., Eto K., et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003, 302:103-106.
132. Ratnikov B.I., Partridge A.W., Ginsberg M.H. Integrin activation by talin. J Thromb Haemost 2005, 3:1783-1790.
133. Law D.A., DeGuzman F.R., Heiser P., et al. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function. Nature 1999, 401:808-811.
134. Law D.A., Nannizzi-Alaimo L., Ministri K., et al. Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets. Blood 1999, 93:2645-2652.
135. Payrastre B., Missy K., Trumel C., et al. The integrin alphaIIb/beta3 in human platelet signal transduction. Biochem Pharmacol 2000, 60:1069-1074.
136. Philips D.R., Prasad K.S., Manganello J., et al. Integrin tyrosine phosphorylation in platelet signaling. Curr Opin Cell Biol 2001, 13:546-554.
137. Phillips D.R., Nannizzi-Alamio L., Prasad K.S. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 2001, 86:246-258.
138. Obergfell A., Eto K., Mocsai A., et al. Coordinate interactions of Csk, Src and Syk kinases with alphaIIbbeta3 initiate integrin signaling to the cytoskeleton. J Cell Biol 2002, 157:265-275.
139. Boylan B., Gao C., Rathore V., et al. Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood 2008, 112:2780-2786.
140. Prevost N., Woulfe D., Tanaka T., et al. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. Proc Natl Acad Sci U S A 2002, 99:9219-9224.
141. Prevost N., Woulfe D.S., Tognolini M., et al. Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1. Blood 2004, 103:1348-1355.
142. Prevost N., Woulfe D.S., Jiang H., et al. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci U S A 2005, 102:9820-9825.
143. Pasterkamp R.J., Giger R.J. Semaphorin function in neural plasticity and disease. Curr Opin Neurobiol 2009, 19:263-274.
144. Roth L., Koncina E., Satkauskas S., et al. The many faces of semaphorins: from development to pathology. Cell Mol Life Sci 2009, 66:649-666.
145. Gherardi E., Love C.A., Esnouf R.M., et al. The sema domain. Curr Opin Struct Biol 2004, 14:669-678.
146. Negishi M., Oinuma I., Katoh H. Plexins: axon guidance and signal transduction. Cell Mol Life Sci 2005, 62:1363-1371.
147. Zhu L., Bergmeier W., Wu J., et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A 2007, 104:1621-1626.
148. Wannemacher K.M., Zhu L., Jiang H., et al. Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D. Blood 2010, 116:5707-5715.
149. Furlong B., Henderson A.H., Lewis M.J., et al. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987, 90:687-692.
150. Whittle B.J., Moncada S. Pharmacological interactions between prostacyclin and thromboxanes. Br Med Bull 1983, 39:232-238.
151. Weksler B.B. Prostacyclin. Prog Hemost Thromb 1982, 6:113-138.
152. Yuhki K., Kojima F., Kashiwagi H., et al. Roles of prostanoids in the pathogenesis of cardiovascular diseases: novel insights from knockout mouse studies. Pharmacol Ther 2011, 129:195-205.
153. Marcus A.J., Broekman M.J., Drosopoulos J.H., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997, 99:1351-1360.
154. Abramow-Newerly M., Roy A.A., Nunn C., et al. RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell Signal 2006, 18:579-591.
155. Yowe D., Weich N., Prabhudas M., et al. RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes. Biochem J 2001, 359:109-118.
156. Nagata Y., Oda M., Nakata H., et al. A novel regulator of G-protein signaling bearing GAP activity for Galphai and Galphaq in megakaryocytes. Blood 2001, 97:3051-3060.
157. Kim S.D., Sung H.J., Park S.K., et al. The expression patterns of RGS transcripts in platelets. Platelets 2006, 17:493-497.
158. Gagnon A.W., Murray D.L., Leadley R.J. Cloning and characterization of a novel regulator of G protein signalling in human platelets. Cell Signal 2002, 14:595-606.
159. Garcia A., Prabhakar S., Hughan S., et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 2004, 103:2088-2095.
160. Berthebaud M., Riviere C., Jarrier P., et al. RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. Blood 2005, 106:2962-2968.
161. Ma P., Cierniewska A., Signarvic R., et al. A newly-identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling. Blood 2012, 119:1935-1945.
162. Gegenbauer K., Elia G., Blanco-Fernandez A., et al. Regulator of G-protein signaling protein 18 integrates activating and inhibitory signaling in platelets. Blood 2012, 119(16):3799-3807.
163. Haslam R.J., Dickinson N.T., Jang E.K. Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost 1999, 82:412-423.
164. Keularts I.M., Van Gorp R.M., Feijge M.A., et al. Alpha2A-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J Biol Chem 2000, 275:1763-1772.
165. Murata T., Ushikubi F., Matsuoka T., et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997, 388:678-682.
166. Quinton T.M., Dean W.L. Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits Ca2+ release from platelet membranes. Biochem Biophys Res Commun 1992, 184:893-899.
167. Grunberg B., Kruse H.J., Negrescu E.V., et al. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP- and cyclic GMP-increasing platelet inhibitors and vasodilators. J Cardiovasc Pharmacol 1995, 25:545-551.
168. Grunberg B., Negrescu E., Siess W. Synergistic phosphorylation of platelet rap1B by SIN-1 and iloprost. Eur J Pharmacol 1995, 288:329-333.
169. Smolenski A. Novel roles of cAMP/cGMP dependent signaling in platelets. J Thromb Haemost 2011, 10(2):167-176.
170. Margarucci L., Roest M., Preisinger C., et al. Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds. Mol Biosyst 2011, 7:2311-2319.
171. Wangorsch G., Butt E., Mark R., et al. Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation. BMC Syst Biol 2011, 5:178.
172. Gambaryan S., Kobsar A., Rukoyatkina N., et al. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J Biol Chem 2010, 285:18352-18363.
173. Hayashi H., Sudo T. Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets. Thromb Haemost 2009, 102:327-335.
174. Zahedi R.P., Lewandrowski U., Wiesner J., et al. Phosphoproteome of resting human platelets. J Proteome Res 2008, 7:526-534.
175. Newman P.J., Newman D.K. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003, 23:953-964.
176. Jackson D.E., Kupcho K.R., Newman P.J. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem 1997, 272:24868-24875.
177. Moraes L.A., Barrett N.E., Jones C.I., et al. PECAM-1 regulates collagen-stimulated platelet function by modulating the association of PI3 Kinase with Gab1 and LAT. J Thromb Haemost 2010, 8:2530-2541.
178. Patil S., Newman D.K., Newman P.J. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 2001, 97:1727-1732.
179. Falati S., Patil S., Gross P.L., et al. Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 2006, 107:535-541.
180. Huber M., Izzi L., Grondin P., et al. The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J Biol Chem 1999, 274:335-344.
181. Beauchemin N., Kunath T., Robitaille J., et al. Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene 1997, 14:783-790.
182. Wong C., Liu Y., Yip J., et al. CEACAM1 negatively regulates platelet-collagen interactions and thrombus growth in vitro and in vivo. Blood 2009, 113:1818-1828.
183. Stalker T.J., Wu J., Morgans A., et al. Endothelial cell specific adhesion molecule (ESAM) localizes to platelet-platelet contacts and regulates thrombus formation in vivo. J Thromb Haemost 2009, 7:1886-1896.
184. Naik M.U., Stalker T.J., Brass L.F., et al. JAM-A protects from thrombosis by suppressing integrin alphaIIbbeta3-dependent outside-in signaling in platelets. Blood 2012, 119:3352-3360.